Read More Pharma Industry News Marinus Pharmaceuticals announces NMPA approval of Ganaxolone for CDKL5 deficiency disorder Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a leader in developing innovative therapeutics for seizure disorders, has achieved a significant milestone… byPallavi MadhirajuJuly 20, 2024